Back to results
US 2026/0083674 A1Published application
Oxazolidinone liposome compositions
AssigneeAkagera Medicines, Inc.
InventorsDmitri B. Kirpotin, Alexander Koshkaryev, Charles O. Noble, Daryl C. Drummond
Life of this patent
Estimating the term…
Abstract
Aspects of the disclosure relate to various liposomal compositions of oxazolidinone compounds, and related methods of manufacturing and using the oxazolidinone liposome compositions. In some embodiments, the liposome compositions have improved storage stability with regard to component degradation.
Claims20
An AKG-28 liposome composition comprising liposomes, the liposomes comprising AKG-28:
- or a pharmaceutically acceptable salt thereof, encapsulated in liposomes comprising hydrogenated soy phosphatidylcholine (HSPC), cholesterol, and methoxy-terminated polyethylene glycol (MW 2000)-distearoylphosphatidyl ethanolamine (PEG(2000)-DSPE).
An AKG-28 liposomal liquid dispersion composition comprising a sulfate salt of AKG-28:
- encapsulated in a unilamellar lipid bilayer vesicle liposomes formed from vesicle forming lipids consisting of:
- hydrogenated soy phosphatidylcholine (HSPC), cholesterol, and methoxy-terminated polyethylene glycol (MW 2000)-distearoylphosphatidyl ethanolamine (PEG(2000)-DSPE).
Dependencies are inferred from the claim text.